Tradestie Institutional Equity Comparison Engine
MPLT vs RACC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RACC Overall Edge
RACC Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RACC (RACC) driven by superior Momentum & Technical, Options & Structure while MPLT counters with relative strength in Growth & Margin. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus RACC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against RACC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MPLT N/M vs RACC N/M Fwd P/E
Growth & Margin Winner
MPLT
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
RACC
1Y -59.3% vs -2.7% ยท 52W Pos 0% vs 2%
Options & Structure Winner
RACC
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (N/A IV)
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap
$356.8M
1M Return
-28.0%
1Y Return
-59.32%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 33.0
Fund 64.0
Flow 67.0
Mom 64.0
RACC
US Equity
RACC
Institutional Equity
$10.02
+0.1% 1D
Market Cap
N/A
1M Return
-1.09%
1Y Return
-2.72%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 39.0
Fund 38.0
Flow 50.0
Mom 38.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MPLT -59.32%
RACC -2.72%
Spread: +75.92 pp (RACC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MPLT TTM Op. Margin: 0.0%
RACC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPLT vs RACC. Trailing 12-month operating profitability (MPLT 0.0% vs RACC N/A) and valuation multiples (MPLT N/M vs RACC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MPLT | RACC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $356.8M | N/A | Larger Scale | MPLT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | MPLT |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | MPLT |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | MPLT |
| Return on Equity (ROE) Capital Efficiency | -74.2% | N/A | Higher ROE | MPLT |
| 52-Week Range Position Momentum | 0% ($6โ$40) | 2% ($10โ$34) | Stronger Trend | RACC |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 79% Vol | 0.16ฮฒ ยท 6% Vol | Lower Realized Risk | RACC |
| Unified Institutional Score Composite Signal | 48.3 / 100 (HOLD) | 42.1 / 100 (HOLD) | Higher Composite | MPLT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MPLT vs RACC Buy Guide
MPLT
BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
RACC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MPLT nor RACC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.